Online Media Kit

Welcome to IPM's Online Media Kit, home to quick links that connect journalists and others to our press statements, key multimedia resources for background information on microbicides and IPM's work, and media highlights. Also learn how to contact experts in the field.

Quick Links


Featured Media Highlights

FEATURED STORY

May 04, 2017 | Economist (UK)

How to protect women against both HIV and pregnancy

A newly-developed vaginal ring releases small doses of drugs over a three-month period More »

FEATURED STORY

August 04, 2016 | Forbes

A Wearable HIV 'Trap' Is Helping Women In Africa Guard Against Infection

The struggle to stem the global HIV/AIDS pandemic may soon see relief from an innovative health product that's shown early success with one group whose infection rates are among the most devastating... More »

FEATURED STORY

February 26, 2016 | The New York Times editorial

Helping Women in Africa Avoid H.I.V.

Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »

Media Highlights

October 05, 2017 | HIV Plus Magazine

Innovative Vaginal Ring Is a New HIV Prevention Method for Women

The International Partnership for Microbicides (IPM) received an award from the United States Agency for International Development (USAID) to support the ongoing research of an HIV-prevention device... More »

October 02, 2017 | The BMJ

Zeda Rosenberg: determined to empower women to prevent HIV infection

Today Rosenberg heads the International Partnership for Microbicides (IPM), a non-profit organisation that is developing a microbicide eluting vaginal ring that has been shown to prevent HIV... More »

September 25, 2017 | MD Magazine

IPM Received Up to $25 Million To Accelerate Vaginal Ring Designed to Reduce HIV-1

The International Partnership for Microbicides (IPM) received up to $25 million throughout 5 years from the United States Agency for International Development to accelerate the potential rollout of... More »

September 18, 2017 | MD Magazine

HIV PrEP Treatment Works Well for At-risk Teenage Boys

In conjunction with the published study, the NIH is funding PrEP therapy studies for African females aged 16-21. The subjects will use a vaginal ring for 6 months, oral PrEP for another 6 months,... More »

September 14, 2017 | CBS Pittsburgh

Vaginal Ring Could Become First HIV Prevention Product For Women

Similar to rings on the market now for birth control and for hormone replacement therapy, this ring doesn’t contain hormones, but a medicine called dapivirine that keeps the virus from making copies... More »

Pages